Evidence map›Paper›PMID 20631096›Full record

ArticleJournal of clinical microbiology2010

Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children.

F P Rivera, T J Ochoa, R C Maves, M Bernal, A M Medina, R Meza, F Barletta, E Mercado, L Ecker, A I Gil and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Epidemiology of enterotoxigenicFrontiers in microbiology · 2025
    Article
  7. High prevalence of enterotoxigenicFrontiers in microbiology · 2025
    Article
  8. Article
  9. Distribution of Escherichia coli Pathotypes along an Urban-Rural Gradient in Ecuador.The American journal of tropical medicine and hygiene · 2023
    Article
  10. Colonizing and Virulence Factors in Enterotoxigenic Escherichia coli from Peru.The American journal of tropical medicine and hygiene · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Chaperone-Usher Pili Loci of Colonization Factor-Negative Human EnterotoxigenicFrontiers in cellular and infection microbiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

F P RiveraUniversidad Peruana Cayetano Heredia, Lima, Peru.
T J Ochoa
R C Maves
M Bernal
A M Medina
R Meza
F Barletta
E Mercado
L Ecker
A I Gil
E R Hall
L Huicho
C F Lanata
Universidad Peruana Cayetano Heredia · PENaval Medical Research Unit Six · PEInstituto de Investigación Nutricional · PEInstituto Nacional de Salud del Niño · PENaval Medical Research Command · USPeruvian University of Applied Sciences · PEThe University of Texas Health Science Center at Houston · US

Funding

Role of virulence heterogeneity in acute and presistent EPEC diarrheaK01TW007405 · FIC · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI OCHOA, THERESA J · 2006 to 2009
$433k
FIC NIH HHS 1K01TW007405FIC NIH HHS K01 TW007405
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) is a major cause of childhood diarrhea. The present study sought to determine the prevalence and distribution of toxin types, colonization factors (CFs), and antimicrobial susceptibility of ETEC strains isolated from Peruvian children. We analyzed ETEC strains isolated from Peruvian children between 2 and 24 months of age in a passive surveillance study. Five E. coli colonies per patient were studied by multiplex real-time PCR to identify ETEC virulence factors. ETEC-associated toxins were confirmed using a GM1-based enzyme-linked immunosorbent assay. Confirmed strains were tested for CFs by dot blot assay using 21 monoclonal antibodies. We analyzed 1,129 samples from children with diarrhea and 744 control children and found ETEC in 5.3% and 4.3%, respectively. ETEC was more frequently isolated from children >12 months of age than from children <12 months of age (P < 0.001). Fifty-two percent of ETEC isolates from children with diarrhea and 72% of isolates from controls were heat-labile enterotoxin (LT) positive and heat-stable enterotoxin (ST) negative; 25% and 19%, respectively, were LT negative and ST positive; and 23% and 9%, respectively, were LT positive and ST positive. CFs were identified in 64% of diarrheal samples and 37% of control samples (P < 0.05). The most common CFs were CS6 (14% and 7%, respectively), CS12 (12% and 4%, respectively), and CS1 (9% and 4%, respectively). ST-producing ETEC strains caused more severe diarrhea than non-ST-producing ETEC strains. The strains were most frequently resistant to ampicillin (71%) and co-trimoxazole (61%). ETEC was thus found to be more prevalent in older infants. LT was the most common toxin type; 64% of strains had an identified CF. These data are relevant in estimating the burden of disease due to ETEC and the potential coverage of children in Peru by investigational vaccines.

Indexed as

Anti-Bacterial AgentsAntibodies, BacterialAntibodies, MonoclonalBacterial ToxinsCase-Control StudiesChild, PreschoolDiarrheaEnterotoxigenic Escherichia coliEnterotoxinsEnzyme-Linked Immunosorbent AssayEscherichia coli InfectionsEscherichia coli ProteinsFemaleHumansInfantMaleAnti-Bacterial AgentsAntibodies, BacterialAntibodies, MonoclonalBacterial ToxinsEnterotoxinsEscherichia coli Proteinsheat-labile enterotoxin, E coliheat stable toxin (E coli)Virulence Factors

Identifiers

PMID20631096
PMCPMC2937683
OpenAlexW2138518611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.